Advances in the Pharmacological Treatment of Dementia
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 5007
Special Issue Editor
Special Issue Information
Dear Colleagues,
The causes of dementia are diverse, and symptomatic or disease-modifying treatment of dementia both have unmet medical needs. Many novel treatments for dementia including small molecules, antibodies, and cell therapy are being developed. These treatments usually target the underlying pathophysiological mechanisms, such as neuroprotection, anti-neuroinflammation, toxic protein removal, neuro-regeneration, etc. This Special Issue will focus on the basic preclinical studies or clinical trials in early stages about the treatment of any kind of dementia, especially the pharmacological approaches. Both original reports and review articles are welcome. To align with the scope of this journal, exploration of the molecular mechanisms or related evidence/information are requested.
We hope to provide a condensed and comprehensive picture of advances in the treatment of dementia in this Special Issue.
Prof. Dr. Chaur-Jong Hu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- dementia
- pharmacological treatment
- preclinical
- disease modifying
